When PrEP (pre-exposure prophylaxis) was released onto the market a decade ago, it was one of the greatest medical advances in the history of HIV (human immunodeficiency virus) — and it still is. If ...
Though an antiretroviral medication called PrEP provides near-perfect protection against HIV, patients must often surmount ...
The CDC estimates 2.2 million Americans could benefit from HIV prevention drugs, but just over a quarter of that group have ...
Long-term Medicaid expansion was linked to substantial growth in PrEP prescribing, with earlier expansion states seeing far ...
Robin O’Donoghue grew up in Fairbanks and first heard about pre-exposure prophylaxis, or PrEP, for preventing HIV transmission when he was in college. PrEP is a daily pill or injection that ...
A little specificity would go a long way in the recommendations of the US Preventive Services Task Force (USPSTF)—that is, if we want health insurance companies to pay for lifesaving HIV prevention ...
The HIV epidemic remains a critical public health priority in the United States. The Ending the HIV Epidemic (EHE) initiative seeks to reduce HIV diagnoses by 75% by 2025 and by 90% by 2030. Certain ...
Increased PrEP usage is linked to decreased HIV diagnosis rates, with a notable decline from 13.0 to 10.6 per 100,000 over a decade. State-level PrEP coverage significantly impacts HIV diagnosis rates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback